Assembly Biosciences ASMB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$38.55M+5.5% | -$38.96M+14.6% | -$39.92M+22.3% | ||
| $122K-6.2% | $129K0.0% | $129K-28.7% | $130K-50.8% | $130K-63.7% | ||
| $5.08M+64.3% | $4.68M+49.9% | $3.97M+19.2% | $3.09M-15.6% | $3.09M-23.1% | ||
| $451K— | $974K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.06M-1.2% | $2.05M— | -$81K+66.3% | -$937K— | $1.08M— | ||
| -$34.51M— | -$36.1M— | —— | —— | —— | ||
| —— | —— | -$55.74M-343% | -$55.85M-330% | -$56.19M-302% | ||
| $85K— | $66K— | —— | —— | —— | ||
| $272.95M+156% | $229.83M+154% | $259.18M+64.1% | $92.96M-36.3% | $106.63M-22.5% | ||
| $147.6M+8.4% | $116.43M-10.9% | $117.83M+2.3% | $134.33M+37.5% | $136.13M+79.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $3.95M— | ||
| $172.89M+451% | $174.67M+493% | $191.21M+783% | $19.27M-11.0% | $31.37M+236% | ||
| $7.71M+65.2% | $20.11M+8.7% | -$5.92M-430% | $4.8M— | $4.66M— | ||
| —— | $3K— | $2.25K— | $1.5K— | $750— | ||
| —— | —— | $1.47M— | —— | —— | ||
| -$807K+25.5% | -$751K+46.4% | -$909K+56.7% | -$1.06M+60.0% | -$1.08M+67.4% | ||
| —— | —— | —— | —— | —— | ||
| $1.06M— | $2.05M— | —— | —— | —— | ||
| $836K-34.5% | $851K-39.9% | $1M-51.1% | $1.14M-54.5% | $1.28M-57.6% | ||
| $147.6M+8.4% | $116.43M-10.9% | $117.83M+2.3% | $134.33M+37.5% | $136.13M+79.1% | ||
| —— | $0-100% | $2.42M-66.7% | $4.83M0.0% | $7.25M+200% | ||
| —— | $5.51M— | $4.13M— | —— | —— | ||
| -$34.51M— | -$36.1M— | —— | —— | —— | ||
| —— | —— | -$55.78M-344% | -$55.85M-332% | -$56.21M-304% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
